Author & Interview Info

Short Bio

Jeff Sharman, MD, is a medical oncologist, clinical investigator, and author whose career has spanned one of the most transformative eras in cancer medicine. As a leader in chronic lymphocytic leukemia (CLL) research, he has helped guide the development of therapies that replaced chemotherapy with targeted treatments and dramatically improved patient outcomes. Through his writing and speaking, Dr. Sharman combines the perspective of a practicing physician, scientist, and historian to illuminate the people, discoveries, and pivotal moments that have shaped modern cancer care. He is the author of Ghosts in the Blood: The Extraordinary History of Chronic Lymphocytic Leukemia.

Medium Bio

Jeff Sharman, MD, is a medical oncologist, clinical investigator, and author whose career has unfolded alongside one of the most remarkable transformations in modern cancer medicine. For more than two decades, he has cared for patients with leukemia, lymphoma, and other blood cancers while helping lead clinical research that advanced new therapies for chronic lymphocytic leukemia (CLL). His work contributed to the transition from chemotherapy-based treatment toward targeted therapies that have dramatically extended and improved the lives of patients with the disease.

As a physician, Dr. Sharman has witnessed scientific breakthroughs not only in research meetings and clinical trials, but also in the lives of the patients who inspired them. That perspective—equal parts clinician, investigator, and storyteller—shaped his desire to explore the history behind these advances and the individuals who made them possible.

In Ghosts in the Blood: The Extraordinary History of Chronic Lymphocytic Leukemia, Dr. Sharman traces the centuries-long journey from mystery and fatalism to precision medicine, revealing the discoveries, setbacks, rivalries, and triumphs that transformed CLL from an incurable disease into one of the great success stories of modern oncology.

Long Bio

Jeff Sharman, MD, is a medical oncologist, clinical investigator, and author whose career has spanned one of the most transformative periods in the history of cancer treatment. Based in Eugene, Oregon, he has spent more than two decades caring for patients with blood cancers while helping lead research that has reshaped the treatment of chronic lymphocytic leukemia (CLL), the most common leukemia in adults.

As a physician and researcher, Dr. Sharman has worked at the intersection of scientific discovery and patient care. Throughout his career, he has participated in the development of therapies that helped move CLL from an era dominated by chemotherapy to one defined by targeted treatments that attack the disease with unprecedented precision. These advances have dramatically improved outcomes for patients and transformed what was once considered an invariably progressive illness into a disease that many individuals can successfully manage for years.

Dr. Sharman serves as Medical Director of Hematology Research for the US Oncology Research Network, one of the largest community-based cancer research organizations in the world. Over the course of his career, he has helped lead clinical trials evaluating many of the therapies that now form the foundation of modern CLL treatment. Yet the most meaningful lessons have come not from laboratories or conference halls, but from the thousands of patients and families who have entrusted him with their care.

Those experiences inspired him to write Ghosts in the Blood: The Extraordinary History of Chronic Lymphocytic Leukemia. More than a history of a disease, the book tells the story of the physicians, scientists, patients, and visionaries whose efforts transformed our understanding of leukemia and helped usher in the era of precision medicine. Drawing on years of research and firsthand experience, Dr. Sharman chronicles a centuries-long journey that stretches from the earliest observations of blood disorders to the development of modern targeted therapies.

As an author and speaker, Dr. Sharman is passionate about making complex medical science accessible to broad audiences. Through his writing, public speaking, and educational initiatives such as CLL Unlocked, he seeks to illuminate the discoveries that shape modern medicine and to help patients better understand the diseases they face. His work reflects a conviction that scientific progress is ultimately a human story—one built on curiosity, perseverance, collaboration, and hope.

Author Photos

Click to download the high resolution image.

Suggested Interview Questions

About the Book

  • What first inspired you to write Ghosts in the Blood?

  • Why did you believe the history of CLL deserved a book of its own?

  • What surprised you most while researching the history?

  • How did your perspective as a practicing oncologist shape the way you told this story?

  • What stories or discoveries nearly ended up on the cutting room floor?

  • Was there a particular patient who influenced your desire to write the book?

  • What do you hope patients and caregivers take away from reading it?

  • What do you hope physicians and scientists take away from it?

The History of Cancer Medicine

  • How has our understanding of cancer changed over the last century?

  • Why did progress against cancer seem so slow for so many decades?

  • What were the most important turning points in the history of leukemia treatment?

  • How did discoveries in one disease ultimately transform many others?

  • What lessons from the history of CLL apply to cancer research more broadly?

  • Which historical figures in oncology do you believe deserve greater recognition?

  • How much of medical progress is driven by individual visionaries versus collaborative effort?

From Chemotherapy to Precision Medicine

  • How do modern targeted therapies differ from the chemotherapy most people associate with cancer treatment?

  • Why has CLL become one of the clearest examples of precision medicine in action?

  • What does the success of targeted therapy teach us about the future of oncology?

  • Have we reached the end of chemotherapy, or does it still have an important role?

  • How has molecular biology changed the way physicians think about cancer?

  • What does "precision medicine" actually mean in practice?

The BTK and BCL2 Revolution

  • How did the development of BTK inhibitors change the field?

  • Were there moments when BTK inhibitors nearly failed to reach patients?

  • What made ibrutinib such a transformative therapy?

  • Why was targeting BCL2 considered such a bold idea?

  • How close did venetoclax come to failing during its development?

  • What can the stories of ibrutinib and venetoclax teach us about scientific perseverance?

  • Looking back, which advances felt revolutionary at the time, and which only became appreciated later?

Innovation and Drug Development

  • What lessons does oncology innovation teach biotech today?

  • Why do some breakthrough therapies succeed while others disappear?

  • How has drug development changed over the course of your career?

  • Are there important lessons from oncology that apply to innovation in other fields?

  • What role does failure play in scientific progress?

  • Why do some scientific ideas take decades to gain acceptance?

  • What distinguishes truly transformative therapies from incremental advances?

  • Are there examples where conventional wisdom slowed scientific progress?

  • What role do patients play in accelerating innovation?

The Human Side of Discovery

  • The book highlights many scientific breakthroughs, but it also tells deeply human stories. Why was that important?

  • What role have patients played in shaping the history of CLL?

  • How have clinical trials changed the lives of patients and families?

  • What moments in your own career have most clearly demonstrated the impact of scientific progress?

  • How do patients experience medical revolutions differently from scientists and physicians?

  • What responsibilities do physicians have when introducing groundbreaking new therapies?

The Future of Oncology

  • What forces are currently reshaping cancer medicine?

  • Which areas of oncology excite you most today?

  • Are we entering a new era of cancer treatment?

  • What advances do you believe historians will someday view as today's turning points?

  • What challenges remain despite the remarkable progress of recent decades?

  • How do artificial intelligence, genomics, and precision medicine fit into the future of cancer care?

  • What gives you the greatest optimism about the future of oncology?

Personal Reflections

  • Why did you choose a career in oncology?

  • What has caring for patients taught you about medicine?

  • How has your understanding of CLL evolved over the course of your career?

  • After researching centuries of medical history, what most impressed you about the process of scientific discovery?

  • What does the story of CLL teach us about hope?

  • If there is one message readers should remember from the book, what would it be?